Clinical Trials Browser

EBV-associated Tumors × Standard of Care × 90 days × Clear all

NCT07349836 2026-01-20

Application of mRNA Immunotherapy Technology in EB Virus Related Diseases

Phase EARLY_PHASE1 Not yet recruiting

EBV-associated Tumors